| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/06/1997 | WO1996036354A3 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | CA2230671A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230375A1 Release of intracellular material |
| 03/06/1997 | CA2230263A1 Reconstituted skin |
| 03/06/1997 | CA2230144A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | CA2229657A1 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 03/06/1997 | CA2229043A1 Protein/(poly)peptide libraries |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759996A1 Peptide-mediated gene transfer |
| 03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
| 03/05/1997 | EP0759993A1 DNA SEQUENCES CODING FOR ENZYMES CAPABLE OF FACILITATING THE SYNTHESIS OF LINEAR $g(a)-1,4 GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS |
| 03/05/1997 | EP0759992A1 Human papilloma virus inhibition by a hairpin ribozyme |
| 03/05/1997 | EP0759989A1 IMPROVED $i(BACILLUS THURINGIENSIS) $g(d)-ENDOTOXIN |
| 03/05/1997 | EP0759985A1 Transgenic arthritic mice |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759938A1 Neurogenic differentiation (neurod) genes and proteins |
| 03/05/1997 | EP0759932A1 Collagen from cell cultures |
| 03/05/1997 | EP0759784A1 Covalent microparticle-drug conjugates for biological targeting |
| 03/05/1997 | EP0759782A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 03/05/1997 | EP0759762A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
| 03/05/1997 | EP0759731A1 DEVICE AND METHODS FOR $i(IN VIVO) CULTURING OF DIVERSE TISSUE CELLS |
| 03/05/1997 | EP0586545B1 Electrophoretic display panel with tapered grid insulators and associated methods |
| 03/05/1997 | CN1144536A Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 03/04/1997 | US5608151 Anti-microbial proteins |
| 03/04/1997 | US5608150 Gene expression; genetic engineering; tomatoes |
| 03/04/1997 | US5608149 Enhanced starch biosynthesis in tomatoes |
| 03/04/1997 | US5607919 Anti-microbial proteins |
| 03/04/1997 | US5607862 Assay for N-terminal type I collagen telopeptide that survives bone resorption in vivo |
| 03/04/1997 | US5607852 Process for attenuated varicella zoster virus vaccine production |
| 03/04/1997 | US5607847 Cells, monoclonal antibodies and hybridomas |
| 03/04/1997 | US5607845 Method for obtaining an increased production of a producing cell line by using a fusion protocol |
| 03/04/1997 | US5607830 Zones for suspension of blood |
| 03/04/1997 | CA2067797C Production and use of human nm23 protein and antibodies therefor |
| 03/04/1997 | CA2058971C Efficient method for identifiable expression of non-selectable genes |
| 02/27/1997 | WO1997007233A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | WO1997007226A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/27/1997 | WO1997007225A2 High efficiency retroviral packaging system |
| 02/27/1997 | WO1997007223A1 Self-deleting vectors for gene therapy |
| 02/27/1997 | WO1997007221A1 Transgenic plant cells and plants having an increased glycolysis rate |
| 02/27/1997 | WO1997007212A1 Opioid antagonists and methods of their use |
| 02/27/1997 | WO1997007204A1 Antibody 105a5 to 'peanut agglutinin' (pna)-binding glycoprotein on cell surfaces |
| 02/27/1997 | WO1997007200A1 Adult oligodendrocyte precursor cell compositions and methods |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007134A1 Traf inhibitors |
| 02/27/1997 | WO1997007132A1 Epitope tagging system |
| 02/27/1997 | WO1997007128A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | WO1997006835A1 Cell culture products |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006659A2 Use of an eriobotrya japonica extract |
| 02/27/1997 | CA2230195A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | CA2229847A1 High efficiency retroviral packaging system |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229540A1 Epitope tagging system |
| 02/27/1997 | CA2229287A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229126A1 Opioid antagonists and methods of their use |
| 02/27/1997 | CA2229061A1 Transgenic plant cells and plants with an increased glycolysis rate |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/27/1997 | CA2226747A1 Cell culture products |
| 02/26/1997 | EP0759474A2 A regulatory factor involved in expression of nitrilase gene, and its gene |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759170A1 Uses of green fluorescent protein |
| 02/26/1997 | EP0759086A1 Method of introducing pathogen resistance in plants |
| 02/26/1997 | EP0759085A1 Chimeric genes comprising a fungus-responsive element |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759078A1 Genes for the synthesis of antipathogenic substances |
| 02/26/1997 | EP0759070A1 Blood-borne mesenchymal cells |
| 02/26/1997 | EP0759069A1 Beta taipoxin as a cell growth factor and method |
| 02/26/1997 | EP0759068A1 $i(RPS2) GENE AND USES THEREOF |
| 02/26/1997 | EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 02/26/1997 | EP0759029A1 Modified milk growth factor |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0659045A4 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins. |
| 02/26/1997 | EP0651824A4 Transcription control element for increasing gene expression in myoblasts. |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606021 Mineralocorticoid receptor compositions and methods |
| 02/25/1997 | US5605835 Three-dimensional matrix containing cells |
| 02/25/1997 | US5605829 Synthetic proteoglycan having ovalbumin core protein linked to heparan sulfate, chondroitin sulfate, dermatan sulfate or combination thereof; promotes differentiation, maintains self-renewal capacity of cultured hematopoietic cells |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605822 Culturing human stem cells in liquid culture medium in the presence of transformed stromal cells |
| 02/25/1997 | US5605814 DNA encoding human prostaglandin receptor EP2 |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605687 Methods and compositions of a polymer (poloxamer) for repair of electrical injury |
| 02/20/1997 | WO1997006277A1 Methods for drug screening |